Johnson Matthey (OTCMKTS:JMPLY) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Johnson Matthey (OTCMKTS:JMPLY) from a sell rating to a buy rating in a report published on Saturday, reports. Zacks Investment Research currently has $90.00 target price on the basic materials company’s stock.

According to Zacks, “Johnson Matthey Plc is a speciality chemicals company focused on its core skills in catalysis, precious metals, fine chemicals and process technology. Its principal activities comprise manufacture of autocatalysts, heavy duty diesel catalysts and pollution control systems, catalysts and components for fuel cells, catalysts and technologies for chemical processes, fine chemicals, chemical catalysts and active pharmaceutical ingredients. The Company also engages in the marketing, refining, and fabrication of precious metals. Its environmental technologies include emission control technologies, process technologies and fuel cells. Its precious metals products include platinum, noble metals, catalysts, chemicals and refining and colour technologies. Its fine chemicals include macfarlan smith, pharmaceutical materials and services and research chemicals. Johnson Matthey Plc is headquartered in London, U.K. “

Several other research analysts also recently issued reports on JMPLY. Barclays downgraded shares of Johnson Matthey from an overweight rating to an equal weight rating in a research report on Tuesday, September 17th. ValuEngine downgraded shares of Johnson Matthey from a hold rating to a sell rating in a report on Friday. Two analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. Johnson Matthey presently has a consensus rating of Hold and a consensus target price of $90.00.

Shares of OTCMKTS:JMPLY opened at $78.90 on Friday. The company’s fifty day moving average price is $76.68 and its 200 day moving average price is $79.45. Johnson Matthey has a 12 month low of $66.88 and a 12 month high of $92.40. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.64 and a quick ratio of 1.00. The firm has a market capitalization of $7.74 billion, a P/E ratio of 13.24, a P/E/G ratio of 1.78 and a beta of 1.51.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Read More: Bond

Get a free copy of the Zacks research report on Johnson Matthey (JMPLY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with's FREE daily email newsletter.